NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION

REPORTS (MANDATED)


Annual Report to Governor & General Assembly on physicians certified, approved medical cannabis programs, amount sold by condition treated, & average price to consumer due Jan. 1 (Chapters 240 & 256, Acts of 2014; Chapters 598, Acts of 2018; Code Health-General Article, sec. 13-3305).

Report to General Assembly on any needed changes to State law governing administration of medical marijuana to a student by authorized school personnel due Dec. 31, 2020 (Chapters 624 & 625, Acts of 2020).

Report to General Assembly on level of competition in the market for medical marijuana, including consequences of oversupply & excessive demand, due Dec. 1, 2015 (Chapters 240 & 256, Acts of 2014).

Report to General Assembly on opioid use disorder treatment using medical cannabis due Jan. 1, 2019 (Chapters 598, Acts of 2018).

Report to General Assembly on revenues necessary, fee levels on licensees, other funding mechanisms & savings in prescription drug costs for Medicaid under program funded by Natalie M. LaPrade Medical Cannabis Compassionate Use Fund due Dec. 1, 2018 (Chapters 598, Acts of 2018).

Report to General Assembly on rules & regulations potentially governing marketing advertising practices of entities licensed & certified by Commission due Jan. 1, 2019 (Chapters 598, Acts of 2018).

Maryland Constitutional Offices & Agencies
Maryland Departments
Maryland Independent Agencies
Maryland Executive Commissions, Committees, Task Forces, & Advisory Boards
Maryland Universities & Colleges
Maryland Counties
Maryland Municipalities
Maryland at a Glance


Maryland Manual On-Line

Search the Manual
e-mail: mdmanual@mdarchives.state.md.us

© Copyright Maryland State Archives